Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Interventional × Ertapenem × Clear all

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Urinary Tract Infections 1

Interventions

Cisplatin 42 Capecitabine 39 Gemcitabine 31 Paclitaxel 29 Oxaliplatin 29 Cyclophosphamide 28 Carboplatin 28 apatinib 27 Radiotherapy 27 tislelizumab 25 Irinotecan 25 Drug Therapy 25 Docetaxel 25 Fluorouracil 24 Bevacizumab 23 fludarabine 16 Nivolumab 16 pembrolizumab 15 Surgical Procedures, Operative 15 Metformin 15 Exercise 15 camrelizumab 13 S 1 (combination) 13 Radiation 13 Pemetrexed 10 Letrozole 10 Doxorubicin 10 Control Groups 10 Vinorelbine 9 Trastuzumab 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03218800 2022-08-11

Ertapenem Administered Subcutaneously Versus Intravenously

Instituto Nacional de Cancer, Brazil

Phase 3 Terminated

Urinary Tract Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡